TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IMTX

Immatics NV

Healthcare · Biotechnology

8.50$ +1.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +119.0% +89.6% -31.4% +133.5% +25.0% +36.5% -19.3%
– +124.3% +92.7% -36.3% +147.8% +19.1% +40.1% -20.0%
– +162.5% +100.8% -35.9% +11.7% +47.1% +8.4% +46.1%
– +127.5% +94.3% -37.4% +149.6% +17.6% +41.9% -22.4%
– +49.8% +7.3% -19.3% -52.9% +416.4% +17.6% +2.0%
– +123,599,900.0% +167.2% -100.0% +0.0% +0.0% – –
– +99.8% +75.1% +46.2% +29.3% – – –
– -3.0% -9.4% +44.0% +24.1% -6.7% +7.0% -2.9%
– +148.4% -4.5% -10.0% +35.8% +43.0% -58.5% -35.5%
– +158.2% +11.8% +22.8% +11.9% +47.1% -56.6% -36.8%
– – +33.3% +44.1% -20.4% +20.6% +9.5% -3.3%
– +1.3% -47.5% +17.8% +333.9% -41.3% +31.9% -96.6%
– – – -72.5% +745.1% +7.0% +164.2% -15.8%
– – – – – – – –
– +0.0% -23.7% +31.1% +8.4% +18.1% +32.6% +14.6%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?